51 results
Keyword Abba Remove keyword
-
List item
National expert: Celine Chu, National Agency For The Safety Of Medicine And Health Products (updated)
- Declaration of interests - 39.19 KB | PDF
- Curriculum Vitae - 27.75 KB | PDF
1_Chu C, Abbara C, Noël_Hudson MS, Thomas_Bourgneuf … Aug;27(4):434_42. 5_Chu C, Abbara C, Tandia M, Publications Page … -
List item
National expert: Giuseppe D'Avenio, Italian Medicines Agency (updated)
- Declaration of interests - 39.5 KB | PDF
- Curriculum Vitae - 36.71 KB | PDF
-
List item
Human medicine European public assessment report (EPAR): Arixtra
fondaparinux sodium, Venous Thrombosis; Pulmonary Embolism; Myocardial Infarction; Angina, Unstable
Date of authorisation: 20/03/2002, Revision: 34, Authorised, Last updated: 11/11/2022 -
List item
Human medicine European public assessment report (EPAR): Rapiscan (updated)
regadenoson, Myocardial Perfusion Imaging
Date of authorisation: 06/09/2010, Revision: 15, Authorised, Last updated: 25/05/2023 -
List item
National expert: Jens-Uwe Bleich, Norwegian Medicines Agency (updated)
- Declaration of interests - 40.09 KB | PDF
- Curriculum Vitae - 25.79 KB | PDF
Charakterisierung biologisch abbaubarer Mikropartikel mit dem Aerosol … -
List item
Human medicine European public assessment report (EPAR): Cervarix (updated)
human papillomavirus1 type 16 L1 protein, human papillomavirus type 18 L1 protein, Papillomavirus Infections; Uterine Cervical Dysplasia; Immunization
Date of authorisation: 20/09/2007, Revision: 39, Authorised, Last updated: 23/05/2023 -
List item
Human medicine European public assessment report (EPAR): Tezspire
tezepelumab, Asthma
Date of authorisation: 19/09/2022,
, Revision: 3, Authorised, Last updated: 19/04/2023
-
List item
Veterinary medicine European public assessment report (EPAR): Rheumocam
meloxicam, Dogs; Horses; Cats; Cattle; Pigs
Date of authorisation: 10/01/2008,
, Revision: 17, Authorised, Last updated: 18/11/2021
-
List item
Human medicine European public assessment report (EPAR): Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (updated)
ChAdOx1-SARS-COV-2, COVID-19 virus infection
Date of authorisation: 29/01/2021,
, , Revision: 28, Authorised, Last updated: 12/05/2023
-
List item
Human medicine European public assessment report (EPAR): Savene
dexrazoxane hydrochloride, Extravasation of Diagnostic and Therapeutic Materials
Date of authorisation: 27/07/2006, Revision: 14, Authorised, Last updated: 08/10/2019 -
List item
National expert: Nils Lilienthal, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 39.19 KB | PDF
- Curriculum Vitae - 30.29 KB | PDF
Lilienthal N, Nicco C, Scherer C, Abbas M, Zada AA, Coriat R, Burkholz … -
List item
National expert: Concetta Quintarelli, Italian Medicines Agency (updated)
- Declaration of interests - 40.79 KB | PDF
- Curriculum Vitae - 39.24 KB | PDF
I, Orlando D, Guercio M, Abbaszadeh Z, Sinibaldi M, Di Cecca … -
List item
National expert: Antonio Cherubini, Italian Medicines Agency (updated)
- Declaration of interests - 41.1 KB | PDF
- Curriculum Vitae - 57.4 KB | PDF
-
List item
National expert: Renato Bassan, European Medicines Agency (updated)
- Declaration of interests - 41.03 KB | PDF
- Curriculum Vitae - 69.3 KB | PDF
-
List item
National expert: Jacob Hendrik van Dieen, European Medicines Agency (updated)
- Declaration of interests - 39.49 KB | PDF
- Curriculum Vitae - 162.05 KB | PDF
-
List item
National expert: Massimo Tempestilli, Italian Medicines Agency (updated)
- Declaration of interests - 39.2 KB | PDF
- Curriculum Vitae - 35.93 KB | PDF
-
List item
National expert: Jose Manuel Zubeldia, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.42 KB | PDF
- Curriculum Vitae - 34.86 KB | PDF
trial. Hourihane JO, Beyer K, Abbas A, Fernández_Rivas M, Turner … -
List item
Withdrawn application: Tibsovo
ivosidenib, date of withdrawal: 13/10/2020, Initial authorisation, Last updated: 16/04/2021 -
List item
Withdrawn application: Blectifor
caffeine citrate, date of withdrawal: 09/03/2017, Initial authorisation, Last updated: 16/05/2017 -
List item
National expert: Jan Welink, Medicines Evaluation Board (updated)
- Declaration of interests - 39.48 KB | PDF
- Curriculum Vitae - 41.63 KB | PDF
-
List item
National expert: Giancarlo Zito, Italian Medicines Agency (updated)
- Declaration of interests - 39.42 KB | PDF
- Curriculum Vitae - 94.07 KB | PDF
-
List item
National expert: Nadine Petitpain, Ministry Of Health (updated)
- Declaration of interests - 41.34 KB | PDF
- Curriculum Vitae - 39.64 KB | PDF
Fourage C, Macro M, Olivier_Abbal P, Fleck C, Mouchel C, Gavard … -
List item
National expert: Massimo Siciliano, Italian Medicines Agency (updated)
- Declaration of interests - 39.2 KB | PDF
- Curriculum Vitae - 49.5 KB | PDF
-
List item
National expert: Carolina Scagnolari, Italian Medicines Agency (updated)
- Declaration of interests - 39.32 KB | PDF
- Curriculum Vitae - 75.69 KB | PDF
-
List item
National expert: Steffen Rex, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 43.47 KB | PDF
- Curriculum Vitae - 80.63 KB | PDF